Modeled reductions in COPD exacerbation rates, mortality, and related medical costs due to increased SITT adoption: PROMETHEUS Italy.
Saved in:
| Title: | Modeled reductions in COPD exacerbation rates, mortality, and related medical costs due to increased SITT adoption: PROMETHEUS Italy. |
|---|---|
| Authors: | Santus P; Department of Biomedical and Clinical Sciences (DIBIC), Division of Respiratory Diseases, Università degli Studi di Milano, Ospedale L. Sacco, ASST Fatebenefratelli- Sacco, Milan, Italy., Oresta B; AstraZeneca, BioPharmaceutical Medical, Milan, Italy., Finocchiaro D; BioPharmaceuticals Market Access & Government Affairs, AstraZeneca, Milan, Italy., De Rosa P; AstraZeneca, BioPharmaceutical Medical, Milan, Italy., Bell J; AstraZeneca, BioPharmaceutical Medical, Cambridge, United Kingdom., Caplen M; Milliman, New York, USA., Carioto J; Milliman, New York, USA. Jennifer.Carioto@milliman.com., Bhatt P; Milliman, New York, USA., Pyenson B; Milliman, New York, USA., Papi A; Department of Respiratory Medicine, University of Ferrara Medical School, Ferrara, Italy. |
| Source: | Respiratory research [Respir Res] 2025 Oct 28; Vol. 26 (1), pp. 296. Date of Electronic Publication: 2025 Oct 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-993X (Electronic) Linking ISSN: 14659921 NLM ISO Abbreviation: Respir Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1465-993X |
|---|---|
| DOI: | 10.1186/s12931-025-03358-8 |
